Surrogate endpoint
Results: 164
# | Item |
---|---|
161 | New NP-C Drug Trial A clinical trial is expected to begin in the summer of 2014 using a Histone Deacetylase Inhibitors (HDACi). The goal of the Phase 1 clinical trial will be to establish the safety and tolerability of aAdd to Reading ListSource URL: www.parseghian.orgLanguage: English - Date: 2013-12-11 15:45:47 |
162 | Frank J. Sasinowski, M.S., M.P.H., J.D. Director, Hyman, Phelps & McNamara, P.C. Director, National Organization for Rare DisordersAdd to Reading ListSource URL: docs.house.govLanguage: English - Date: 2014-05-19 13:50:11 |
163 | An upper limit for macromolecular crowding effectsAdd to Reading ListSource URL: www.ncbi.nlm.nih.govLanguage: English |
164 | Guidance for Industry Clinical Trial EndpointsAdd to Reading ListSource URL: www.fda.govLanguage: English |